Upgrade to SI Premium - Free Trial

Ensysce Biosciences (ENSC)

0.51 -0.01 (1.92%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai October 21, 2026 8:01 AM - StreetInsider Cantor Fitzgerald Starts Ensysce Biosciences Inc. (ENSC) at Overweight October 20, 2026 6:21 AM - StreetInsider Form 8-K/A Ensysce Biosciences, For: Aug 05 October 16, 2026 6:04 AM - SEC Filing Form 8-K Ensysce Biosciences, For: Sep 25 September 29, 2026 8:31 AM - SEC Filing Ensysce Biosciences submits Phase 2a protocol for CY200 to UK regulator September 24, 2026 8:02 AM - StreetInsider Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA September 24, 2026 8:01 AM - StreetInsider Ensysce Biosciences presents at PainWeek, joins FDA psychedelics hearing September 15, 2026 9:16 AM - StreetInsider Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation September 15, 2026 9:16 AM - StreetInsider Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs September 14, 2026 8:01 AM - StreetInsider Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation September 2, 2026 8:32 AM - StreetInsider Ensysce completes enrollment in final stage of opioid study August 31, 2026 8:32 AM - StreetInsider Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study August 31, 2026 8:31 AM - StreetInsider Form 8-K Ensysce Biosciences, For: Aug 25 August 25, 2026 5:12 PM - SEC Filing Form 8-K Ensysce Biosciences, For: Aug 24 August 24, 2026 5:14 PM - SEC Filing Form D Ensysce Biosciences, August 20, 2026 2:14 PM - SEC Filing Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium August 20, 2026 8:01 AM - StreetInsider Form SCHEDULE 13D/A Ensysce Biosciences, Filed by: GOWER BOB G August 18, 2026 12:31 PM - SEC Filing Form 4 Ensysce Biosciences, For: Apr 23 Filed by: GOWER BOB G August 18, 2026 6:06 AM - SEC Filing Form 10-Q Ensysce Biosciences, For: Jun 30 August 13, 2026 4:33 PM - SEC Filing Form 8-K Ensysce Biosciences, For: Aug 13 August 13, 2026 4:20 PM - SEC Filing Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights August 13, 2026 4:15 PM - StreetInsider Form 3 Ensysce Biosciences, For: Aug 05 Filed by: Morrison James William August 10, 2026 4:06 PM - SEC Filing Form 8-K/A Ensysce Biosciences, For: Aug 05 August 6, 2026 3:45 PM - SEC Filing Why Investors Are Watching These Healthcare Movers August 6, 2026 12:32 PM - StreetInsider Form 8-K Ensysce Biosciences, For: Aug 05 August 6, 2026 8:21 AM - SEC Filing Ensysce Biosciences acquires Cy Biopharma with up to $77M financing August 6, 2026 8:01 AM - StreetInsider Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing August 6, 2026 8:01 AM - StreetInsider Full Article List